Literature DB >> 1330854

[High affinity binding of Y-25130 for serotonin 3 receptor].

M Sakamori1, S Takehara, M Setoguchi.   

Abstract

The binding of Y-25130 on serotonin 3 (5-HT3) receptors was evaluated by examining its effect on 3H-BRL 43694 (3H-granisetron) binding to rat cerebral cortex membranes in comparison with those of granisetron, ondansetron and metoclopramide. Y-25130, granisetron, ondansetron, metoclopramide, 5-HT and 2-methyl-5-HT displaced the specific binding of 3H-granisetron to the synaptosomal membranes in a concentration-dependent manner. The rank order of potency for inhibition of 3H-granisetron binding by the test compounds was Y-25130 not equal to granisetron greater than ondansetron much greater than 2-methyl-5-HT not equal to 5-HT not equal to metoclopramide. To determine the manner of interaction between Y-25130 and 5-HT3 receptors, Scatchard analysis of 3H-granisetron specific binding to the membranes of the cerebral cortex in the absence or presence of various concentrations of Y-25130 was performed. It was indicated that Y-25130 exerted a typical competitive-type inhibition of 3H-granisetron binding. The present study indicates that Y-25130 binds competitively to 5-HT3 receptors with high affinity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330854     DOI: 10.1254/fpj.100.137

Source DB:  PubMed          Journal:  Nihon Yakurigaku Zasshi        ISSN: 0015-5691


  4 in total

1.  Receptor occupancy theory-based analysis of interindividual differences in antiemetic effects of 5-HT3 receptor antagonists.

Authors:  Hideaki Ayuhara; Risa Takayanagi; Kiyoshi Okuyama; Koichi Yoshimoto; Takeshi Ozeki; Haruko Yokoyama; Yasuhiko Yamada
Journal:  Int J Clin Oncol       Date:  2009-12-05       Impact factor: 3.402

2.  Theoretical evaluation of antiemetic effects of 5-HT3 receptor antagonists for prevention of vomiting induced by cisplatin.

Authors:  Hironori Nakamura; Haruko Yokoyama; Risa Takayanagi; Koichi Yoshimoto; Akihiro Nakajima; Kiyoshi Okuyama; Osamu Iwase; Yasuhiko Yamada
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-01-28       Impact factor: 2.441

3.  Comparison of azasetron and ondansetron for preventing postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery.

Authors:  Mi Ja Yun; Yoon Hee Kim; A Rm Kim
Journal:  Yonsei Med J       Date:  2009-12-29       Impact factor: 2.759

4.  A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy.

Authors:  Hee Yeon Lee; Hoon-Kyo Kim; Kyung Hee Lee; Bong-Seog Kim; Hong Suk Song; Sung Hyun Yang; Joon Hee Kim; Yeul Hong Kim; Jong Gwang Kim; Sang-We Kim; Dong-Wan Kim; Si-Young Kim; Hee Sook Park
Journal:  Cancer Res Treat       Date:  2014-01-15       Impact factor: 4.679

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.